SGYP

Synergy Pharmaceuticals, Inc. News Headlines

$2.74
*  
0.02
0.74%
Get SGYP Alerts
*Delayed - data as of Oct. 20, 2014  -  Find a broker to begin trading SGYP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SGYP After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Synergy Pharma Reaches Halfway Mark For Second Phase 3 Trial Of Plecanatide
9/18/2014 6:15:00 AM - RTT News


Synergy Pharmaceuticals Could Be A Diamond In The Rough
9/8/2014 12:30:00 PM - Seeking Alpha


Trouble For Synergy Pharmaceuticals Shorts With Pending SP-333 Trial Results
8/15/2014 7:24:00 PM - Seeking Alpha


Synergy Pharma (SGYP) Posts Wider-than-Expected Loss in Q2 - Analyst Blog
8/13/2014 3:03:00 PM - Zacks.com


Update: Synergy Pharmaceuticals Patient Enrollment
7/28/2014 7:01:00 AM - Seeking Alpha


Jazz Pharmaceuticals/Concert Pharmaceuticals Start Study - Analyst Blog
7/22/2014 5:25:00 PM - Zacks.com


Anacor's Kerydin to Be Commercialized by Sandoz in the U.S. - Analyst Blog
7/22/2014 5:05:00 PM - Zacks.com


Anacor Pharmaceuticals, Inc. (ANAC) in Focus: Stock Surges 6.76% - Tale of the Tape
7/22/2014 8:44:00 AM - Zacks.com


Astellas Up on Pipeline Update, Oncology in Focus (revised) - Analyst Blog
7/21/2014 4:07:46 PM - Zacks.com


Synergy Pharmaceuticals Progresses with Mid-Stage Candidate - Analyst Blog
7/18/2014 6:15:00 PM - Zacks.com


Salix-Pharming's Ruconest Gets FDA Nod for HAE - Analyst Blog
7/18/2014 6:00:00 PM - Zacks.com


Astellas' Isavuconazole Gets QIDP for Invasive Candidiasis - Analyst Blog
7/17/2014 5:50:00 PM - Zacks.com


Genocea Biosciences, Inc. (GNCA) in Focus: Stock Rises 7.52% - Tale of the Tape
7/17/2014 8:44:00 AM - Zacks.com


Weakness Seen in Lannett Company (LCI): Stock Tumbles 17.1% - Tale of the Tape
7/17/2014 8:36:00 AM - Zacks.com


Astellas Up on Pipeline Update, Oncology in Focus - Analyst Blog
7/16/2014 3:03:00 PM - Zacks.com


Zafgen's Beloranib Gets Orphan Drug Status in the EU - Analyst Blog
7/14/2014 11:40:00 AM - Zacks.com


Sector Update: Health-Care Stocks Flat Pre-Market; Abbott Adds 1% on Sale of Generics Business to Mylan
7/14/2014 8:47:17 AM - MT Newswires


Sector Update: Health Care
7/14/2014 8:45:47 AM - MT Newswires


Strength Seen in La Jolla Pharmaceutical Co. (LJPC): Stock Shoots 19% - Tale of the Tape
7/14/2014 8:44:00 AM - Zacks.com


Sarepta Plunges on Eteplirsen Study Results - Analyst Blog
7/11/2014 5:00:00 PM - Zacks.com


Regado's REGULATE-PCI Study Under Clinical Hold - Analyst Blog
7/10/2014 6:30:00 PM - Zacks.com


Astellas Seeks FDA Nod for Fungal Infection Treatment - Analyst Blog
7/10/2014 5:30:00 PM - Zacks.com


Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock up 8.37% - Tale of the Tape
7/10/2014 8:44:00 AM - Zacks.com


Weakness Seen in TherapeuticsMD (TXMD): Stock Tumbles 8.4% - Tale of the Tape
7/10/2014 8:34:00 AM - Zacks.com


Incyte Earns Milestone Payment on Japanese Approval of Jakavi - Analyst Blog
7/9/2014 6:50:00 PM - Zacks.com